Loading...
Uploaded by ElsGlobalMedicalNews on Jun 29, 2011
On the second day of Avastin hearings at the FDA, Genentech officials took the podium and in a two-hour session argued why Avastin should be approved for metastatic breast cancer.
News & Politics
Standard YouTube License
Load more suggestions
All Comments